Robert Dudley
Plus aucun poste en cours
Fortune : 3 078 $ au 31/03/2024
Profil
Robert Michael Dudley was the founder of TransCode Therapeutics, Inc. (founded in 2016) where he held the titles of President, Chief Executive Officer & Director until 2024, and Artemes Technologies, Inc. (founded in 2012) where he held the titles of Chairman & Chief Executive Officer until 2015.
He also worked as an Associate at Harvard Medical School from 1973 to 1975.
Dudley received his undergraduate degree from Kent State University (Ohio).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/12/2023 | 4 507 ( 0,07% ) | 3 078 $ | 31/03/2024 |
Anciens postes connus de Robert Dudley
| Sociétés | Poste | Fin |
|---|---|---|
| TRANSCODE THERAPEUTICS, INC. | Founder | 13/01/2024 |
| Artemes Technologies, Inc. | Chief Executive Officer | 01/10/2015 |
| Harvard Medical School | Corporate Officer/Principal | 01/12/1975 |
Formation de Robert Dudley
| Kent State University (Ohio) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TRANSCODE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Artemes Technologies, Inc. |
